CD74 and cancer: The results also enable us to develop cell-penetrating-peptides (CPPs) to facilitate cellular intake of AKT inhibitors associated by cargo; and/or to establish unique CD74 antibody-drug conjugate (ADC) with AKT inhibitor to target CD74-positive cancer cells selectively and efficiently.